__NUXT_JSONP__("/drugs/Lapuleucel-T", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:b,chebiId:b,chemicalFormula:b,definition:"A cell-based vaccine targets tumors expressing the HER2\u002Fneu marker.  HER-2\u002Fneu is a growth factor receptor, and its overexpression has been associated with a number of cancers including breast, ovarian, colon and lung cancers.  APC8024 comprise of autologous antigen-presenting peripheral blood mononuclear cells (APCs) that have been exposed to HER2\u002Fneu protein and can be administered to the patient.  These cells may stimulate an antitumor T-cell response to cancer cells expressing HER2\u002Fneu.",fdaUniiCode:"J5Z87L8ROA",identifier:"C2057",preferredName:a,semanticType:"Immunologic Factor",subclassOf:["C1987"],synonyms:["APC 8024","APC8024","DN24-02","LAPULEUCEL-T",a,"Neuvenge"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FLapuleucel-T",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Lapuleucel-T","","2021-10-30T13:37:18.313Z")));